Peptonic Medical AB (publ) is extending the partnership with Farmasiet that will bring the entire VagVital product portfolio to the Norwegian market. Farmasiet, Norway's largest online pharmacy, is set to launch these innovative products designed to address specific needs in intimate care, encompassing diagnosis, treatment, and prevention. The introduction of VagVital products is scheduled to commence in early 2024.

Vernivia is already available at Farmasiet. By leveraging Farmasiet's robust presence in the Norwegian market and Peptonic Medical's scientific expertise, this extension marks a significant step in providing customers with high-quality intimate care solutions.